eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Roche Diagnostics - Comment

Roche Diagnostics - Comment

Document ID: FDA-2011-D-0577-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: November 11 2011, at 12:00 AM Eastern Standard Time
Date Posted: December 16 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 15 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 14 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f6ab66
View Document:  View as format xml

View Comment

Roche Diagnostics respectfully submits the attached comments to Docket No. FDA-2011-D-0577-0001

Attachments:

Roche Diagnostics Comments on Draft Benefit-Risk Guidance

Title:
Roche Diagnostics Comments on Draft Benefit-Risk Guidance

View Attachment: View as format msw8 View as format pdf

Related Comments

    View All
Total: 15
Francisco Martinez Murillo - Comment
Public Submission    Posted: 09/27/2011     ID: FDA-2011-D-0577-0003

Nov 14,2011 11:59 PM ET
NeuroPace, Inc. - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2011-D-0577-0004

Nov 14,2011 11:59 PM ET
Novartis - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0005

Nov 14,2011 11:59 PM ET
Stephanie Bechtold - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0006

Nov 14,2011 11:59 PM ET
Roche Diagnostics - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0007

Nov 14,2011 11:59 PM ET